American Gene Technologies® International Email Formats
Biotechnology Research • 
9713 Key West Ave, 500, United States • 21-50 Employees
American Gene Technologies® International Email Formats
American Gene Technologies® International uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@americangene.com), used 78.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@americangene.com | 78.6% |
{first name}.{last name} | john.doe@americangene.com | 14.3% |
{first name}{last name} | johndoe@americangene.com | 7.1% |
Key Contact at American Gene Technologies® International
Jeff Galvin
Chief Executive Officer
Company overview
| Headquarters | 9713 Key West Ave, 500, Rockville, Maryland 20850, US |
| Phone number | +13013372101 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Gene Therapy, Cell Therapy, Immuno-Oncology, Cancer Therapeutics, Autosomal Disorders, Hiv And Hepatitis-C Viral Therapeutics |
| Founded | 2007 |
| Employees | 21-50 |
| Socials |
About American Gene Technologies® International
American Gene Technologies® International Inc. (AGT™) is a private biotechnology company pursuing cures and treatments for infectious diseases, cancers, and monogenic disorders. AGT™'s emerging gene and cell therapeutics programs are designed to: ✅ Create immunotherapy for HIV disease with gene-modified T cells ✅ Activate innate T cell immunity capable of killing all tumor cells with its vector used in immuno-oncology ✅ Treat PKU by bringing a functional gene into cells that express a dysfunctional gene due to mutation ✅ Advance clinically to provide human proof of concept For over a decade, AGT™ has developed, tested, and banked thousands of lentiviral vectors that can be adapted to the specific needs of new target diseases. AGT™ has developed gene therapy for diseases using this rapid gene delivery platform. GENE THERAPIES AGT™’s platform allows it to pursue clinical “cures” for complex diseases. The company has developed patent-protected gene therapeutics that are breakthroughs in medicine. *** See our extensive award winning patents on our website *** HIV/AIDS Immunotherapy for HIV disease with gene-modified T cells IMMUNO-ONCOLOGY Activates innate T cell immunity capable of killing all tumor cells with its vector used in immuno-oncology PHENYLKETONURIA (PKU) Treats PKU by bringing a functional gene into cells that express a dysfunctional gene due to mutation AGT™'s Core Objectives ✔️ Leverage our lentivirus platform to create highly-effective targeted genetic medicines ✔️ Create solutions for patients across a spectrum of infectious diseases, cancers and inherited disorders ✔️ Collaborate with leading medical researchers from around the globe To learn more and get in touch with American Gene Technologies® Inc., contact us today at https://www.americangene.com/contact-us/
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
American Gene Technologies® International has 10 employees across 7 departments.
Departments
Number of employees
American Gene Technologies® International Tech Stack
Discover the technologies and tools that power American Gene Technologies® International's digital infrastructure, from frameworks to analytics platforms.
WordPress plugins
Form builders
WordPress plugins
Miscellaneous
Analytics
Maps
WordPress plugins
JavaScript libraries
CDN
Font scripts
France
Netherlands
United Kingdom
India
Canada
Frequently asked questions
4.8
40,000 users
